{
  "_id": "c3821428abf01e52bd5ac9ab7c4d6a95319db890811e1a2f55be2bd817b3170b",
  "feed": "market-watch",
  "title": "Pfizer asks FDA to authorize its 3-dose COVID vaccine for children under 5",
  "text": "<p>The Pfizer PFE-BioNTech BNTX vaccine was also found to be safe and well-tolerated among the children in studies, according to the companies.</p><p>FDA clearance could come before the end of the month. If the Centers for Disease Control and Prevention signs off, the last remaining group of people in the U.S. — roughly 19 million young children — would get access to shots at doctors' offices, pharmacies and other locations</p><p>The FDA is also weighing a request from Moderna Inc. MRNA to authorize two doses of its vaccine for children under 6 years.</p><p>The agency has scheduled meetings of outside medical advisers on June 14-15 to discuss data and review the applications from Pfizer-BioNTech's and Moderna's vaccine trials in young children.</p><p>An expanded version of this report appears on WSJ.com.</p><p>Also popular on WSJ.com:</p><p>Forget LinkedIn — your next job offer could come via Slack.</p><p>Russian oil producers stay one step ahead of sanctions.</p><p>Pfizer asks FDA to authorize its 3-dose COVID vaccine for children under 5</p>",
  "published": "2022-06-01T22:34:00.000Z",
  "tags": [
    {
      "id": "US5949181045",
      "nexusId": "10031144",
      "name": "Microsoft Corporation",
      "offsets": []
    }
  ]
}